1 To whom correspondence should be addressed are myriad other reasons why a particular protein may not crystallize well. One of these is protein heterogeneity Purified recombinant human immunodeficiency virus type (McPherson, 1990) . Heterogeneity can arise from many sources 1 (HIV-1) integrase and certain deletion mutants exhibit (oxidation, post-translational modification, etc.) , or can result heterogeneity consistent with proteolysis at a site close to from contaminating proteins which are not removed during the C-terminus. Electrospray ionization mass spectrometric purification. We have observed that recombinantly expressed analysis indicated that proteolytic cleavage generated a HIV-1 and HIV-2 integrase consistently co-purify with a protein missing five residues from the C-terminus. PCR slightly smaller protein ( Figure 1 , lanes 1 and 2). A smaller mutagenesis of amino acids on either side of the cleavage protein also co-purifies when integrase is expressed with a site identified two changes which were subsequently shown histidine tag (HT) at its N-terminus and purified by affinity to prevent clipping when proteins were expressed and chromatography. This suggests that the contaminating protein purified from Escherichia coli: the substitution of Arg284, is a truncated form of integrase, rather than an Escherichia coli the residue on the C-terminal side of the cleavage site, by protein, an interpretation confirmed by N-terminal sequencing either glycine or lysine. The introduction of either of these . The size of the contaminating protein mutations into full-length integrase did not affect in vitro also changes with the size of the integrase derivative ( Figure  3Ј processing or strand transfer activities. Thus, the incorp-1, lane 4). The presence of a co-purifying protein correlates oration of either of these mutations is likely to be beneficial without exception with the extreme C-terminus of integrase. when homogeneity of HIV-1 integrase is a concern, as in (Hickman ected mutagenesis et al., 1994; unpublished data) . We hypothesized that, during expression in E.coli, integrase Introduction As part of the retroviral life cycle, virally encoded integrase removes two nucleotides from each 3Ј end of newly reverse transcribed viral DNA and then inserts the viral DNA into host cell target DNA (for reviews, see Katz and Skalka, 1994) . This integration of viral DNA is required for the subsequent generation of new viral particles and is an obvious step to target in the effort to identify anti-HIV drugs. We are interested in the three-dimensional structure of HIV-1 integrase, both as a means of understanding the chemistry of catalysis and as a foundation for rational drug design. However, structural work on recombinantly expressed HIV-1 integrase has been impeded by its biophysical properties: low solubility and a proclivity for aggregation. A point mutation was recently described, F185K, which renders HIV-1 integrase (IN 1-288 ; superscripts denote the amino acids comprising integrase or its domains) soluble and monodisperse at high protein concentrations (Jenkins et al., 1995 (Jenkins et al., , 1996 . This mutation allowed us to determine the structure of the catalytic domain of HIV-1 integrase, IN , by X-ray crystallography (Dyda et al., 1994) . The structure of another fragment of integrase, IN 220-270 , a stretch of 50 amino acids located close to the C- has been determined using nuclear magnetic resonance (NMR) integrase without histidine tag (HT) or F185K/C280S substitutions; 2, HIVspectroscopic methods (Eijkelenboom et al., 1995; Lodi et al., 1995) . tional chromatography as described previously . Untagged, full-length HIV-2 integrase was extracted from the insoluble pellet and precipitated using ammonium sulfate as described by Craigie et al. (1995) for HIV-1 integrase. It was further purified by chromatography on phosphocellulose in 1.5 M urea-containing buffers (gradient elution from 0.1 to 1.0 M NaCl). Unless stated otherwise, all other integrase derivatives contain F185K and C280S mutations as appropriate. The first mutation, F185K, renders integrase and its deletion mutants soluble while the second prevents time-dependent aggregation in the absence of reducing agents (Jenkins et al., 1995 (Jenkins et al., , 1996 .
Histidine-tagged (HT) proteins such as ϩHT IN 50-288 and ϩHT IN 1-288 were purified using Ni 2ϩ affinity chromatography Fig. 3 . SDS-PAGE analysis of purified ϩHT IN 50-288 with mutations at as described previously (Jenkins et al., 1996) . To screen rapidly ϩHT IN 217-288 derivatives were purified on a small scale by batch Ni 2ϩ affinity chromatography as follows: is a substrate for a bacterial protease that either cuts the protein Induced cells (50 ml of culture induced at OD 600 nm ϭ 0.8) at a specific site close to the C-terminus, or exoproteolytically were resuspended in 1 ml of 25 mM HEPES, pH 7.5, 0.1 mM removes a certain number of accessible residues. A truncated EDTA and frozen in liquid nitrogen. Cells were then thawed protein is seen by SDS-PAGE when cells expressing on ice and buffer was added to bring the solution to final IN are lyzed directly in sample buffer, indicating that, concentrations of 0.3 mg/ml lysozyme, 0.5 M NaCl and 2 mM at least in this case, proteolysis occurs during expression, not β-mercaptoethanol (β-ME). After 30 min on ice, lyzed cells during subsequent purification. Proteolytic removal of amino were frozen in liquid nitrogen, allowed to thaw on ice and acids is a concern as it has been reported that integrase missing then centrifuged in a Beckman TL-100 ultracentrifuge at five amino acids from its C-terminus is only partially active 100 000 g for 45 min at 4°C. (All subsequent steps were for strand transfer (Drelich et al., 1992) , one of the activities carried out at 4°C.) Chelating Sepharose (Pharmacia) was of integrase that can be monitored in vitro using short oligonuequilibrated with 50 mM NiSO 4 according to the manufaccleotide substrates that mimic the ends of viral DNA. Thus, turer's procedures and resuspended 1:1 (v/v) with buffer A these last few amino acids may be crucial contributors to (20 mM HEPES, pH 7.5, 0.5 M NaCl, 2 mM β-ME) containing enzyme activity, or may be required to maintain the three-5 mM imidazole (Im). This suspension was added 1:1 (v/v) dimensional structure of the protein. Although protein heteroto the supernatant above and the mixture rotated slowly for 4 geneity arising from proteolysis may not be the direct cause h to batch adsorb the protein on the resin. The resin was pelleted of our inability to obtain suitable integrase crystals, we by low-speed centrifugation and the supernatant removed. The undertook to determine the site of cleavage and devise methods resin was washed with an equal volume of buffer A containing to eliminate it.
5 mM Im by rotating again for 5 min and centrifuging. This Materials and methods was repeated 3-4 times. The resin was then washed 3-4 times as described above with buffer A containing 60 mM Im. The PCR-based mutagenesis protein was subsequently eluted using a minimal volume of Amino acid changes were introduced at residue 283 or 284 buffer A containing 0.8 M Im by rotating for 20 min. Imidazole and a stop codon introduced after residue 283, by PCR-based was removed from the final preparation by dialysis against 20 mutagenesis using plasmid DNA encoding IN 1-288 /F185K/ mM Tris, pH 7.5, 1 M NaCl, 1 mM EDTA and 1 mM C280S as the template DNA and the appropriate primers dithiothreitol (DTT). Purified proteins were analyzed for het-(BioServe). The resulting PCR fragments were gel-purified, erogeneity by SDS-PAGE and for enzymatic activity as digested with NdeI and BamHI and then ligated with NdeIdescribed below. For the purification of ϩHT IN 213-288 and BamHI-digested pET-15b (Novagen), which adds a 20 amino ϩHT IN 217-288 mutant proteins, β-ME and DTT were omitted. acid tag containing six histidine residues to the N-terminus of each expressed protein. The gene sequences of all mutated Sample preparation for electrospray ionization mass proteins were confirmed by DNA sequencing (New England spectrometry (ESI-MS) BioLabs CircumVent Thermal Cycle Sequencing Kit).
The histidine tag (HT) was removed from purified ϩHT Protein expression and purification IN 50-288 by thrombin cleavage as described previously . The protein was dialyzed for Ͼ70 h against 5% Expression of various integrase proteins in E.coli strain acetic acid-0.1 mM DTT with several buffer changes and then BL21(DE3) was as described previously . Untagged, full-length HIV-1 integrase was purified by convenfor 24 h against 5% acetic acid alone. The extensive protein to analysis.
Integrase enzyme assays 10% glycerol,~0.4 pmol substrate and various concentrations of protein as indicated in Figure 4A and B. Samples were The 32 P-labelled substrate was prepared by annealing 5Ј-ACTGCTAGAGATTTTCCACAC (AE117) and 5Ј-GTGTGGincubated at 37°C for 60 min and the reactions stopped by the addition of 16 µl of sequencing gel loading dye. Samples were AAAATCTCTAGCAGT (AE118) as described previously (Engelman and Craigie, 1992) . The standard reaction buffer heated at 100°C for 3-5 min and 2 µl electrophoresed in 20% acrylamide-urea gels. The results were visualized by (final volume 16 µl) contained 25 mM MOPS, pH 7.2, 10 mM β-ME, 0.1 mg/ml bovine serum albumin, 7.5 mM MnCl 2 , autoradiography.
tography and analyzed by SDS-PAGE (Figure 3) . Two of the (compare the last two lanes in Figure 3) . containing the U5 viral end sequence, while strand transfer measures the subsequent insertion of an oligonucleotide with a Naturally occurring mutants were identified using the NCBI (National a recessed 3Ј end into a second oligonucleotide (Sherman and Center for Biotechnology Information) BLAST program by searching available peptide sequence databases. Fyfe, 1990; Craigie et al., 1991) . In contrast to the results of Drelich et al. (1992) , truncation at residue 283 did not lead to a measurable decrease in either Mn 2ϩ -dependent 3Ј processing Gel filtration of -HT IN 217-288 /R284G or strand transfer activity. This is consistent with the observaThe C-terminal domain incorporating one of the mutations tions of for HIV-1 integrase fused at its Nthat prevents cleavage, ϩHT IN 217-288 /R284G, was purified terminus to the maltose-binding protein, which showed no from the soluble fraction of lysed E.coli cells essentially as decrease in in vitro activity when nine amino acids were described for IN 50-212 /F185K (Jenkins et al., 1995) , except removed from its C-terminus. As might be expected from the that reducing agents were omitted. After removal of the HT natural variation in HIV-1 integrase sequences, ϩHT IN 1-288 / by thrombin cleavage, protein was concentrated to~19 mg/ml R284G was as active in both assays as the unmutated version; using a Centriprep 10 (Amicon) and dialyzed against 1 M this was also true for ϩHT IN 1-288 /R284K. All activity assays NaCl, 20 mM Tris, pH 7.5, 1 mM EDTA, 10% (w/v) glycerol.
were repeated using proteins from which the HT were removed Analytical gel filtration (sample size 15 µl) was performed by thrombin cleavage and the results were unaffected (data on a Pharmacia SMART System using a pre-packed Superdex not shown). 200 PC 3.2/30 column; the column was equilibrated in dialysis
The dramatic improvement of sample homogeneity resulting buffer at 4°C prior to sample loading. from either the R284G or R284K change is demonstrated in Figure 5 , where a construct comprising the C-terminal domain Results and discussion alone, IN , was mutated to incorporate each change. Purified -HT IN 217-288 /R284G was determined by analytical Electrospray ionization mass spectrometry (ESI-MS) was used to determine the molecular mass of the contaminant present gel filtration to elute at a position consistent with a dimer ( Figure 6 ). We had previously observed that purified ϩHT in integrase preparations. A sample of -HT IN 50-288 was dialyzed extensively into 5% acetic acid-0.1 mM eluted as a mixture of aggregated (~30%) and dimeric (~70%) material (unpublished data). The elimination remove interfering buffer components. The resulting ESI mass spectrum is shown in Figure 2 . The series of paired mass-toof aggregation in the case of IN 217-288 /R284G is not a consequence of the removal of residues 213-216 as purified ϩHT charge (m/z) peaks indicate that there is a predominant species and a minor one comprising~5% of the total sample. The IN 213-288 /R284G is predominantly dimeric (Ͼ95%; data not shown), but may be either a result of substitution at R284 or deconvoluted spectrum is shown in Figure 2B . The molecular mass of the major species (26 948 Da) corresponds to the the use of slightly different buffers during purification of the various C-terminal domains. intact protein (calculated molecular mass ϭ 26 925 Da) bound to a sodium ion (23 Da). Assuming that the minor species In summary, we have introduced a mutation into HIV-1 integrase, substitution of residue 284 with either Gly or Lys, (26 302 Da) also binds a single sodium ion, it corresponds to an integrase derivative missing five amino acids from its Cthat prevents protein heterogeneity caused by a presumed E.coli protease. This mutation will be valuable in improving the terminus, since -HT IN 50-283 has a calculated molecular mass of 26 282 Da. homogeneity of our protein preparations for crystallographic studies, particularly in cases such as IN where at least Inspection of the database of sequenced viral strains demonstrated that although the extreme C-terminus of HIV-1 integrase 25% of the unmutated protein was proteolytically processed. We presume such an approach can be readily applied to other is highly conserved, the residues on either side of the putative site of proteolysis, Ser283 and Arg284, are substituted in viral proteins that are clipped during expression or purification, since both PCR mutagenesis and the small-scale protein strains, either singly or in combination, with glycine (Table I,  A) . These are substitutions, therefore, that do not eliminate purification method described here are fairly rapid procedures.
As two substitutions at position 284 were able to prevent in vivo integrase activity. Guided by this information, we created a series of IN derivatives in which the formation of a truncated protein, this indicates that the problematic E.coli protease is most likely an endoprotease, mutations were introduced at positions 283 or 284 (Table I, B) .
To determine the extent of protein heterogeneity with rather than an exoprotease which successively removes the last five amino acids and then stops. HIV-2 integrase, a protein different amino acids at positions 283 and 284, each ϩHT IN 50-288 derivative was purified by batch Ni 2ϩ affinity chromathat is also proteolytically processed when recombinantly expressed (see Figure 1 , lane 2), has an Ala-Arg sequence located close to its C-terminus (Arg is seven amino acids from end), reminiscent of the Ser283-Arg284 sequence in HIV-1 integrase. This suggests that similar mutations in this protein may also improve its homogeneity. Our approach of site-directed mutagenesis is clearly not the only method to circumvent a protease problem during expression. For example, it is possible to express proteins in host E.coli strains defective for certain proteases (Das, 1990) , although this may be a time-consuming and haphazard approach unless the sequence at the susceptible site is already known. This information may not even be sufficient as, although we have characterized the cleavage site in HIV integrase, we have been unable to identity an E.coli protease responsible for hydrolysis prior to an arginine residue. An alternative approach which was tried, moving the His tag to the C-terminus which should select during purification for molecules which are not cut at the C-terminus, was not successful for HIV-1 integrase as an entirely new set of proteolytic products was observed (T.Jenkins, personal communication).
